View in EDS PDF Full Text

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.

Saved in:
Bibliographic Details
Title: Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.
Authors: Miller YE; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States., Ghosh M; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States., Merrick DT; Department of Pathology, University of Colorado, Aurora, CO, United States., Kubala B; Cancer Center Clinical Trial Core, University of Colorado, Aurora, CO, United States., Szabo E; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Bengtson L; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Kocherginsky M; Department of Preventative Medicine, Northwestern University, Evanston, IL, United States., Helenowski IB; Department of Preventative Medicine, Northwestern University, Evanston, IL, United States., Benante K; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States., Schering T; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States., Kim J; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States., Kim H; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, United States., Ha D; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States., Bergan RC; Fred and Pamela Buffett Cancer Center, Division of Oncology & Hematology, Genitourinary Oncology, University of Nebraska, Evanston, IL, United States., Khan SA; Department of Surgery, Northwestern University, Omaha, NE, United States., Keith RL; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States.
Source: Frontiers in oncology [Front Oncol] 2023 Aug 30; Vol. 13, pp. 1204726. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37711198
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Miller+YE%22">Miller YE</searchLink>; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States.<br /><searchLink fieldCode="AU" term="%22Ghosh+M%22">Ghosh M</searchLink>; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.<br /><searchLink fieldCode="AU" term="%22Merrick+DT%22">Merrick DT</searchLink>; Department of Pathology, University of Colorado, Aurora, CO, United States.<br /><searchLink fieldCode="AU" term="%22Kubala+B%22">Kubala B</searchLink>; Cancer Center Clinical Trial Core, University of Colorado, Aurora, CO, United States.<br /><searchLink fieldCode="AU" term="%22Szabo+E%22">Szabo E</searchLink>; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Bengtson+L%22">Bengtson L</searchLink>; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Kocherginsky+M%22">Kocherginsky M</searchLink>; Department of Preventative Medicine, Northwestern University, Evanston, IL, United States.<br /><searchLink fieldCode="AU" term="%22Helenowski+IB%22">Helenowski IB</searchLink>; Department of Preventative Medicine, Northwestern University, Evanston, IL, United States.<br /><searchLink fieldCode="AU" term="%22Benante+K%22">Benante K</searchLink>; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States.<br /><searchLink fieldCode="AU" term="%22Schering+T%22">Schering T</searchLink>; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Kim+H%22">Kim H</searchLink>; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Ha+D%22">Ha D</searchLink>; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States.<br /><searchLink fieldCode="AU" term="%22Bergan+RC%22">Bergan RC</searchLink>; Fred and Pamela Buffett Cancer Center, Division of Oncology & Hematology, Genitourinary Oncology, University of Nebraska, Evanston, IL, United States.<br /><searchLink fieldCode="AU" term="%22Khan+SA%22">Khan SA</searchLink>; Department of Surgery, Northwestern University, Omaha, NE, United States.<br /><searchLink fieldCode="AU" term="%22Keith+RL%22">Keith RL</searchLink>; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2023 Aug 30; Vol. 13, pp. 1204726. <i>Date of Electronic Publication: </i>2023 Aug 30 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37711198
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2023.1204726
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1204726
    Titles:
      – TitleFull: Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Miller YE
      – PersonEntity:
          Name:
            NameFull: Ghosh M
      – PersonEntity:
          Name:
            NameFull: Merrick DT
      – PersonEntity:
          Name:
            NameFull: Kubala B
      – PersonEntity:
          Name:
            NameFull: Szabo E
      – PersonEntity:
          Name:
            NameFull: Bengtson L
      – PersonEntity:
          Name:
            NameFull: Kocherginsky M
      – PersonEntity:
          Name:
            NameFull: Helenowski IB
      – PersonEntity:
          Name:
            NameFull: Benante K
      – PersonEntity:
          Name:
            NameFull: Schering T
      – PersonEntity:
          Name:
            NameFull: Kim J
      – PersonEntity:
          Name:
            NameFull: Kim H
      – PersonEntity:
          Name:
            NameFull: Ha D
      – PersonEntity:
          Name:
            NameFull: Bergan RC
      – PersonEntity:
          Name:
            NameFull: Khan SA
      – PersonEntity:
          Name:
            NameFull: Keith RL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 08
              Text: 2023 Aug 30
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1